Low grade gliomas guide-lines elaborated by the tumor section of Spanish Society of Neurosurgery.
Autors de IIS La Fe
Autors aliens a IIS La Fe
- Tejada Solis, Sonia
- Gonzalez Sanchez, Josep
- Iglesias Lozano, Irene
- Plans Ahicart, Gerard
- Pérez Núñez A
- Meana Carballo, Leonor
- Gil Salu, Jose Luis
- Fernandez Coello, Alejandro
- Garcia Romero, Juan Carlos
- Rodriguez de Lope Llorca, Angel
- Garcia Duque, Sara
- Diez Valle, Ricardo
- Narros Gimenez, Jose Luis
- Working Group of the SENEC
Grups d'Investigació
Abstract
Adult low-grade gliomas (Low Grade Gliomas, LGG) are tumors that originate from the glial cells of the brain and whose management involves great controversy, starting from the diagnosis, to the treatment and subsequent follow-up. For this reason, the Tumor Group of the Spanish Society of Neurosurgery (GT-SENEC) has held a consensus meeting, in which the most relevant neurosurgical issues have been discussed, reaching recommendations based on the best scientific evidence. In order to obtain the maximum benefit from these treatments, an individualised assessment of each patient should be made by a multidisciplinary team. Experts in each LGG treatment field have briefly described it based in their experience and the reviewed of the literature. Each area has been summarized and focused on the best published evidence. LGG have been surrounded by treatment controversy, although during the last years more accurate data has been published in order to reach treatment consensus. Neurosurgeons must know treatment options, indications and risks to participate actively in the decision making and to offer the best surgical treatment in every case.
Copyright © 2022. Published by Elsevier España, S.L.U.
Dades de la publicació
- ISSN/ISSNe:
- 2529-8496, 2529-8496
- Tipus:
- Article
- Pàgines:
- 139-152
- PubMed:
- 36446721
Neurocirugia (english Edition)
Documents
- No hi ha documents
Filiacions
Keywords
- Cirugía tumor cerebral; Consenso; Consensus; Gliomas bajo grado; Guía tratamiento; Low grade glioma; Surgery brain tumor; Treatment guideline
Projectes associats
EVALUACIÓN DEL ÍNDICE DE PROLIFERACIÓN KI-67 COMO PREDICTOR DE RECIDIVA EN MENINGIOMAS CEREBRALES GRADO I DE LA OMS. COMPARACIÓN CON LA ESCALA DE RESECCIÓN QUIRÚRGICA DE SIMPSON.
Investigador Principal: LUIS RICARDO PRAT ACÍN
2013_0041_CRC_PRAT . FUNDACION MUTUA MADRILEÑA . 2013
CILENGITIDA EN PACIENTES CON GLIOBLASTOMA MULTIFORME RECIEN DIAGNOSTICADO Y CON PROMOTOR METILADO DEL GEN MGMT- ESTUDIO MULTICENTRICO, ABIERTO Y CONTROLADO EN FASE III PARA EVALUAR CILENGITIDA EN COMBINACION CON EL TRATAMIENTO CONVENCIONAL (TEMOZOLOMIDA C O N RADIOTERAPIA CONCOMIANTE, SEGUIDO POR EL TRATAMIENTO DE MANTENIMIENTO CON TEMOZOLOMIDA) FRENTE AL TRATAMIENTO CONVENCIONAL SOLO (CENTRIC)
Investigador Principal: GASPAR REYNES MUNTANER
EMD121974-011
ESTUDIO OBSERVACIONAL RETROSPECTIVO SOBRE LA EFECTIVIDAD DE GLIOLAN® EN EL TRATAMIENTO DE LOS GLIOMAS MALIGNOS EN ESPAÑA (ESTUDIO VISIONA).
Investigador Principal: CARLOS BOTELLA ASUNCION
GEB-ACA-2011-01
ESTUDIO OBSERVACIONAL PROSPECTIVO ACERCA DEL MANEJO PERIOPERATORIO / PERIPROCEDIMIENTO DE LOS FÁRMACOS ANTITROMBÓTICOS EN EL “MUNDO REAL”: REGISTRO REQXAA.
Investigador Principal: RAQUEL FERRANDIS COMES
SEC-API-2019-01 . 2021